Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

818 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer

NCT04360941

Conditions
Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +10 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Hope Clinical Trials Cancer Centre Leicester, United Kingdom
View Trial Details
Recruiting

Sacituzumab Govitecan In TNBC

NCT04230109

Conditions
Breast Diseases, Breast Neoplasms, ER-negative Breast Cancer, +9 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Massachusetts General Hospital - North Shore Cancer Center Danvers, Massachusetts, United States
View Trial Details
Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

NCT05633654

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
View all 356 locations
View Trial Details
Recruiting

The TASTY-steering Study

NCT07258563

Conditions
Breast Diseases, Breast Neoplasms, Endocrine Gland Neoplasms, +18 more
Locations
  • Amsterdam UMC Amsterdam, Netherlands
  • Rijnstate Ziekenhuis Arnhem, Netherlands
  • Van Weel-Bethesda Ziekenhuis Dirksland, Netherlands
  • Ziekenhuisvoorzieningen Gelderse Vallei Ede, Netherlands
View Trial Details
Recruiting

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

NCT07137416

Conditions
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +24 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions